NCT06482086 2024-12-05Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid CancerWest China HospitalPhase 2 Recruiting75 enrolled
NCT02870569 2019-03-01Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid CancerSuzhou Zelgen Biopharmaceuticals Co.,LtdPhase 2 Completed48 enrolled